Literature DB >> 29124667

Improving survival in ACLF: growing evidence for use of G-CSF.

D A Simonetto1, V H Shah1, P S Kamath2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29124667      PMCID: PMC6089351          DOI: 10.1007/s12072-017-9834-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  12 in total

1.  Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.

Authors:  Arshi Khanam; Nirupama Trehanpati; Vishal Garg; Chandan Kumar; Hitendra Garg; Barjesh C Sharma; Shiv K Sarin
Journal:  Liver Int       Date:  2014-04       Impact factor: 5.828

2.  A case of granulocyte-colony stimulating factor/plasmapheresis-induced activation of granulocyte-colony stimulating factor-positive hepatic progenitors in acute-on-chronic liver failure.

Authors:  Anna Chiara Piscaglia; Vincenzo Arena; Stefano Passalacqua; Antonio Gasbarrini
Journal:  Hepatology       Date:  2015-04-08       Impact factor: 17.425

3.  Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.

Authors:  Chandan Kumar Kedarisetty; Lovkesh Anand; Ankit Bhardwaj; Ajeet Singh Bhadoria; Guresh Kumar; Ashish Kumar Vyas; Paul David; Nirupama Trehanpati; Archana Rastogi; Chhagan Bihari; Rakhi Maiwall; Hitendra Kumar Garg; Chitranshu Vashishtha; Manoj Kumar; Vikram Bhatia; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2015-03-04       Impact factor: 22.682

4.  Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.

Authors:  Vishal Garg; Hitendra Garg; Arshi Khan; Nirupama Trehanpati; Ashish Kumar; Barjesh Chander Sharma; Puja Sakhuja; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2011-11-23       Impact factor: 22.682

Review 5.  Sepsis in alcohol-related liver disease.

Authors:  Thierry Gustot; Javier Fernandez; Gyongyi Szabo; Agustin Albillos; Alexandre Louvet; Rajiv Jalan; Richard Moreau; Christophe Moreno
Journal:  J Hepatol       Date:  2017-06-22       Impact factor: 25.083

6.  Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.

Authors:  Virendra Singh; Arun K Sharma; R Lakshmi Narasimhan; Ashish Bhalla; Navneet Sharma; Ratiram Sharma
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

7.  Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy.

Authors:  Stamatios E Theocharis; Lila J Papadimitriou; Zoi P Retsou; Alexandra P Margeli; Sotirios S Ninos; John D Papadimitriou
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.

Authors:  Laurent Spahr; Jean-François Lambert; Laura Rubbia-Brandt; Yves Chalandon; Jean-Louis Frossard; Emiliano Giostra; Antoine Hadengue
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

9.  Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.

Authors:  C Di Campli; M A Zocco; N Saulnier; A Grieco; G Rapaccini; G Addolorato; C Rumi; A Santoliquido; G Leone; G Gasbarrini; A Gasbarrini
Journal:  Dig Liver Dis       Date:  2007-10-26       Impact factor: 4.088

10.  Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure.

Authors:  Xue-Zhang Duan; Fang-Fang Liu; Jing-Jing Tong; Hao-Zhen Yang; Jing Chen; Xiao-Yan Liu; Yuan-Li Mao; Shao-Jie Xin; Jin-Hua Hu
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

View more
  6 in total

Review 1.  Pathogenesis of Acute-on-Chronic Liver Failure in Patients With Infection.

Authors:  Gyongyi Szabo
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

2.  Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.

Authors:  Xiaogang Xiang; Dechun Feng; Seonghwan Hwang; Tianyi Ren; Xiaolin Wang; Eszter Trojnar; Csaba Matyas; Ruidong Mo; Dabao Shang; Yong He; Wonhyo Seo; Vijay H Shah; Pal Pacher; Qing Xie; Bin Gao
Journal:  J Hepatol       Date:  2019-11-29       Impact factor: 25.083

3.  Stimulating More Than Just the Granulocytes: Drug-Induced Liver Injury From Filgrastim.

Authors:  Disha Sharma; Ben L Da; Anusha Vittal; Devika Kapuria; Theo Heller; Gil Ben Yakov
Journal:  ACG Case Rep J       Date:  2019-06-14

Review 4.  Approaches for patients with very high MELD scores.

Authors:  Florent Artru; Didier Samuel
Journal:  JHEP Rep       Date:  2019-02-23

Review 5.  Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.

Authors:  Mireia Casulleras; Ingrid W Zhang; Cristina López-Vicario; Joan Clària
Journal:  Cells       Date:  2020-12-08       Impact factor: 6.600

6.  Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Wei Wu; Shanshan Sun; Yijie Wang; Ruihong Zhao; Haotang Ren; Zhiwei Li; Hong Zhao; Yi Zhang; Jifang Sheng; Zhi Chen; Yu Shi
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.